Recent Advancements in Ex Vivo CRISPR Cas9 Gene Editing for Hemoglobinopathies: A Systematic Review of Clinical and Preclinical Progress. Al-Shatrah Veterinary and Biological Sciences Journal 2026, 2 (3), 98-113.